StonvexLoading…
StonvexStonvexStonvexCore line items from TXG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $642.82M | $610.78M | $618.73M | $516.41M |
Operating Income | $-60.98M | $-194.56M | $-265.33M | $-167.94M |
Net Income | $-43.54M | $-182.63M | $-255.10M | $-166.00M |
EPS (Diluted) | $-0.35 | $-1.52 | $-2.18 | $-1.46 |
Total Assets | $1.04B | $918.64M | $965.14M | $1.03B |
Total Liabilities | $245.04M | $208.50M | $224.10M | $223.24M |
Cash & Equivalents | $473.97M | $344.07M | $359.28M | $219.75M |
Free Cash Flow OCF − CapEx | $130.12M | $-5.73M | $-63.80M | $-165.27M |
Shares Outstanding | 127.69M | 122.29M | 119.10M | 115.20M |